|
|||||
|
|
Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens |
|
| Authors: | Heramvand Nadia Masyuk Maryna Muessig Johanna M Nia Amir M Karathanos Athanasios Polzin Amin Valgimigli Marco Gurbel Paul A Tantry Udaya S Kelm Malte Jung Christian |
| Institution: | 1.Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstra?e 5, 40225, Düsseldorf, Germany ;2.CARID: Cardiovascular Research Institute Düsseldorf, Düsseldorf, Germany ;3.Cardiocentro Ticino, Lugano and University of Bern, Bern, Switzerland ;4.Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, USA ; |
| Abstract: | Journal of Thrombosis and Thrombolysis - Tirofiban is a glycoproteine (GP) IIb/IIIa receptor antagonist, which inhibits platelet-platelet aggregation and is a potential adjunctive antithrombotic... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |